Coimbatorebharathi Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.20 M
- Company Age 5 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth -5.53%
- Ebitda -5.53%
- Net Worth -14.05%
- Total Assets -7.94%
About Coimbatorebharathi Biotech
Coimbatorebharathi Biotech Private Limited (CBPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 May 2019 (Five years and eight months 19 days old ). Its registered office is in Coimbatore, Tamil Nadu, India.
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Chandrasekar and Kajamohideen Sheikbasheerahamed serve as directors at the Company.
Company Details
-
Location
Coimbatore, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73100TZ2019PTC032129
-
Company No.
032129
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 May 2019
-
Date of AGM
29 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Coimbatorebharathi Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandrasekar
|
Director | 14-May-2019 | Current |
|
Kajamohideen Sheikbasheerahamed
|
Director | 14-May-2019 | Current |
Financial Performance of Coimbatorebharathi Biotech.
Coimbatorebharathi Biotech Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 5.53% decrease in profit. The company's net worth observed a substantial decline by a decrease of 14.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Coimbatorebharathi Biotech?
Unlock access to Coimbatorebharathi Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Coimbatorebharathi Biotech?
Unlock and access historical data on people associated with Coimbatorebharathi Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Coimbatorebharathi Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Coimbatorebharathi Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.